AbCellera is a biotechnology company specializing in the discovery and development of therapeutic antibodies. Utilizing its proprietary technology platform, AbCellera rapidly screens and analyzes immune systems to identify potent antibodies for treating various diseases, including infectious diseases, cancer, and autoimmune disorders.